Robertson Stephens Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Robertson Stephens Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $57,349 - $67,298	56 Added 22.67%	303 $318,000
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $218,150 - $264,583	247 New	247 $259,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $7,058 - $7,663	-10 Reduced 2.73%	356 $256,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $5,739 - $7,243	10 Added 2.81%	366 $252,000
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $32,352 - $43,591	-59 Reduced 14.22%	356 $210,000
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $246,974 - $289,848	415 New	415 $289,000
Q4 2020 Feb 10, 2021	SELL	$478.3 - $607.98 $330,027 - $419,506	-690 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$544.75 - $658.21 $375,877 - $454,164	690 New	690 $386,000

1,500

83M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Robertson Stephens Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Robertson Stephens Wealth Management, LLC with notifications on news.